VIVUS (VVUS), Orexigen (OREX) Surge on Arena Approval
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
VIVUS Inc. (Nasdaq: VVUS), Orexigen (Nasdaq: OREX) are moving to the highs of the day after rival Arena (Nasdaq: ARNA) won FDA approval for diet pill lorcaserin.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
- Holcim said to acquire part of James Hardie's EU business
- Citadel has shed over 80% of aggregate risk from Situational Awareness portfolio - CNBC
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
